HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of malakoplakia with trimethoprim-sulfamethoxazole.

Abstract
A case is described of malakoplakia involving the urinary tract and retroperitoneum with recalcitrant infection due to Escherichia coli which was not responsive to seemingly appropriate antibiotics and surgery for drainage, but which subsequently responded to treatment with trimethoprim-sulfamethoxazole. It is speculated that this drug combination may be helpful because of the ability of trimethoprim to enhance the killing of viable undigested microorganisms inside malakoplakic macrophages.
AuthorsE G Maderazo, B B Berlin, C Morhardt
JournalUrology (Urology) Vol. 13 Issue 1 Pg. 70-3 (Jan 1979) ISSN: 0090-4295 [Print] United States
PMID375536 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Trimethoprim
  • Sulfamethoxazole
Topics
  • Adult
  • Drug Therapy, Combination
  • Escherichia coli Infections (drug therapy)
  • Female
  • Humans
  • Malacoplakia (drug therapy)
  • Retroperitoneal Space
  • Sulfamethoxazole (administration & dosage, therapeutic use)
  • Trimethoprim (administration & dosage, therapeutic use)
  • Urologic Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: